In conclusion, enacting a model‐based triage of a symptomatic CRC pathway could decrease the burden on endoscopy while maintaining diagnostic accuracy as targeted validation of our Cox model suggested that using the model may lead to a similar proportion of cancers detected while reducing the number of colonoscopies performed compared to the equivalent binary f‐Hb cut offs. This evidence concerns the gene GSTM1 and colorectal carcinoma.